Tandem Diabetes Care Reaches Analyst Target Price
May 06, 2020 at 10:42 AM EDT
In recent trading, shares of Tandem Diabetes Care Inc (TNDM) have crossed above the average analyst 12-month target price of $84.09, changing hands for $84.79/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..